checkAd

     101  0 Kommentare Physitrack PLC – Interim Report: December 2020 – November 2021 - Seite 2


    "Our Q4 2021 results were outstanding. Technological adoption and investment in our space are accelerating, and we continue to grow the business in these exciting times for our market. We have enhanced both our SaaS and our Virtual Care businesses through our acquisitions and through product development, and we look forward to continue on our growth trajectory in 2022."

    Financial outlook
    As outlined within the IPO prospectus, Physitrack's Board of Directors has adopted a set of financial targets linked to the Company's Strategy as set forth below:

    • Growth: Physitrack aims to achieve annual organic sales growth exceeding 30 per cent in the medium term, further supplemented by impact from future add-on acquisitions.
    • Margin: Physitrack targets an EBITDA margin of 40-45 per cent in the medium term, with potential short term margin extractions due to add-on acquisitions impacting margins negatively.

    There are no changes to these financial targets.

    Change of year end
    In order to more closely align our financial year end with the purchasing cycles of our customers the Board has made the decision to change the Group's financial year end from 30 November to 31 December. All relevant reporting dates have been updated in the ‘Financial calendar' section of our investor website: https://www.physitrackgroup.com/investors/financial-calendar.

    Webcast presentation
    A webcast presentation with dial-in possibility will be held at 10.00 a.m. CET today, with CEO Henrik Molin and CFO Charlotte Goodwin. Both the webcast and the telephone conference offer an opportunity to ask questions. The presentation will be held in English and will be available on https://www.physitrackgroup.com/investors/reports-presentations after the webcast conference.

    Webcast link: https://tv.streamfabriken.com/physitrack-group-q4-2020-2021
    Dial in details for participants:
    SE: +46856642693
    UK: +443333009266
    US: +16467224903

    Enquiries regarding this announcement should be addressed to
    Investor contact: Adam Nilsson, +46 (0) 707 46 44 21, ir@physitrack.com
    Media contact: Adam Nilsson, +46 (0) 707 46 44 21, media@physitrack.com

    About Physitrack
    Physitrack, founded in 2012, is a global digital healthcare provider, mainly focused on the B2B physiotherapy and musculoskeletal care market. With staff on four continents, customers in 17 time zones, and patients in 187 countries, we are a truly global company.

    Seite 2 von 3



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Physitrack PLC – Interim Report: December 2020 – November 2021 - Seite 2 LONDON, UK / ACCESSWIRE / January 26, 2022 / Physitrack (STO:PTRK)Financial highlights for the fourth quarter and twelve month period ended 30 November 2021Fourth quarter 2020/21 (September 2021 - November 2021)Revenue of EUR 2.4m (1.0m) for the …